Although Akt was found constitutively activate in JAK2V617F mutated cells in vitro[29], [30] and in V617F transgenic [38] or knock-in mice [19], the contribution of PI3K/Akt signaling to the pathogenesis of MPN is still poorly characterized. This evidence concerns the gene AKT1 and myeloproliferative disorder.